Morgan Stanley Immutep LTD Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Immutep LTD stock. As of the latest transaction made, Morgan Stanley holds 15,077 shares of IMMP stock, worth $28,193. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,077
Previous 105,301
85.68%
Holding current value
$28,193
Previous $211,000
84.36%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding IMMP
# of Institutions
32Shares Held
1.92MCall Options Held
264KPut Options Held
90.5K-
Black Rock Inc. New York, NY839KShares$1.57 Million0.0% of portfolio
-
Meridian Wealth Management, LLC398KShares$745,1010.04% of portfolio
-
Jane Street Group, LLC New York, NY126KShares$234,8380.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA113KShares$210,3800.0% of portfolio
-
Xy Capital LTD Central, K3108KShares$202,6120.08% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $162M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...